These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 21088413)
1. Inflammatory bowel disease as a risk factor for colorectal cancer. Lukas M Dig Dis; 2010; 28(4-5):619-624. PubMed ID: 21088413 [TBL] [Abstract][Full Text] [Related]
2. Natural history of low grade dysplasia in patients with primary sclerosing cholangitis and ulcerative colitis. Venkatesh PG; Jegadeesan R; Gutierrez NG; Sanaka MR; Navaneethan U J Crohns Colitis; 2013 Dec; 7(12):968-73. PubMed ID: 23433613 [TBL] [Abstract][Full Text] [Related]
3. Nearly a Third of High-Grade Dysplasia and Colorectal Cancer Is Undetected in Patients with Inflammatory Bowel Disease. Eluri S; Parian AM; Limketkai BN; Ha CY; Brant SR; Dudley-Brown S; Efron JE; Fang SG; Gearhart SL; Marohn MR; Meltzer SJ; Bashar S; Truta B; Montgomery EA; Lazarev MG Dig Dis Sci; 2017 Dec; 62(12):3586-3593. PubMed ID: 28631086 [TBL] [Abstract][Full Text] [Related]
4. High Risk of Advanced Colorectal Neoplasia in Patients With Primary Sclerosing Cholangitis Associated With Inflammatory Bowel Disease. Shah SC; Ten Hove JR; Castaneda D; Palmela C; Mooiweer E; Colombel JF; Harpaz N; Ullman TA; van Bodegraven AA; Jansen JM; Mahmmod N; van der Meulen-de Jong AE; Ponsioen CY; van der Woude CJ; Oldenburg B; Itzkowitz SH; Torres J Clin Gastroenterol Hepatol; 2018 Jul; 16(7):1106-1113.e3. PubMed ID: 29378311 [TBL] [Abstract][Full Text] [Related]
5. High Adherence to Surveillance Guidelines in Inflammatory Bowel Disease Patients Results in Low Colorectal Cancer and Dysplasia Rates, While Rates of Dysplasia are Low Before the Suggested Onset of Surveillance. Singh K; Al Khoury A; Kurti Z; Gonczi L; Reinglas J; Verdon C; Kohen R; Bessissow T; Afif W; Wild G; Seidman E; Bitton A; Lakatos PL J Crohns Colitis; 2019 Sep; 13(10):1343-1350. PubMed ID: 30918959 [TBL] [Abstract][Full Text] [Related]
6. Progression of low-grade dysplasia to advanced neoplasia based on the location and morphology of dysplasia in ulcerative colitis patients with extensive colitis under colonoscopic surveillance. Navaneethan U; Jegadeesan R; Gutierrez NG; Venkatesh PG; Hammel JP; Shen B; Kiran RP J Crohns Colitis; 2013 Dec; 7(12):e684-91. PubMed ID: 23916526 [TBL] [Abstract][Full Text] [Related]
7. Colorectal Strictures in Patients With Inflammatory Bowel Disease Do Not Independently Predict Colorectal Neoplasia. Axelrad JE; Faye A; Slaughter JC; Harpaz N; Itzkowitz SH; Shah SC Inflamm Bowel Dis; 2022 Jun; 28(6):855-861. PubMed ID: 34319381 [TBL] [Abstract][Full Text] [Related]
8. Colorectal cancer in inflammatory bowel disease: what is the real magnitude of the risk? Dyson JK; Rutter MD World J Gastroenterol; 2012 Aug; 18(29):3839-48. PubMed ID: 22876036 [TBL] [Abstract][Full Text] [Related]
10. Management of low and high-grade dysplasia in inflammatory bowel disease: the gastroenterologists' perspective and current practice in the United Kingdom. Thomas T; Nair P; Dronfield MW; Mayberry JF Eur J Gastroenterol Hepatol; 2005 Dec; 17(12):1317-24. PubMed ID: 16292084 [TBL] [Abstract][Full Text] [Related]
11. Incidence, Risk Factors, and Outcomes of Colorectal Cancer in Patients With Ulcerative Colitis With Low-Grade Dysplasia: A Systematic Review and Meta-analysis. Fumery M; Dulai PS; Gupta S; Prokop LJ; Ramamoorthy S; Sandborn WJ; Singh S Clin Gastroenterol Hepatol; 2017 May; 15(5):665-674.e5. PubMed ID: 27916678 [TBL] [Abstract][Full Text] [Related]
13. Statin Exposure Is Not Associated with Reduced Prevalence of Colorectal Neoplasia in Patients with Inflammatory Bowel Disease. Shah SC; Glass J; Giustino G; Hove JRT; Castaneda D; Torres J; Kumar A; Elman J; Ullman TA; Itzkowitz SH Gut Liver; 2019 Jan; 13(1):54-61. PubMed ID: 30400722 [TBL] [Abstract][Full Text] [Related]
14. Endoscopy/surveillance in inflammatory bowel disease. Ahmadi AA; Polyak S Surg Clin North Am; 2007 Jun; 87(3):743-62. PubMed ID: 17560423 [TBL] [Abstract][Full Text] [Related]
15. Outcome after surveillance of low-grade and indefinite dysplasia in patients with ulcerative colitis. Pekow JR; Hetzel JT; Rothe JA; Hanauer SB; Turner JR; Hart J; Noffsinger A; Huo D; Rubin DT Inflamm Bowel Dis; 2010 Aug; 16(8):1352-6. PubMed ID: 20027656 [TBL] [Abstract][Full Text] [Related]
16. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease. Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187 [TBL] [Abstract][Full Text] [Related]
17. Colorectal cancer in inflammatory bowel disease: the risk, pathogenesis, prevention and diagnosis. Kim ER; Chang DK World J Gastroenterol; 2014 Aug; 20(29):9872-81. PubMed ID: 25110418 [TBL] [Abstract][Full Text] [Related]